The authors evaluated hiPSC-derived respiratory organoids, which contained respiratory epithelial cells, immune cells, fibroblasts, and vascular endothelial cells, for their potential to model respiratory syncytial virus infection and support pharmaceutical research.
[Life Science Alliance]